MedTrace Logo

Prospective Registry of Elderly ESUS With PFO

NCT05238610 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2022-02-14

No results posted yet for this study

Summary

Patent foramen ovale (PFO) is associated with an increased risk of stroke. PFO-closure was effective in preventing stroke in young stroke patients less than age 60 presented as an embolic stroke of undetermined source (ESUS). However, the benefit of PFO-closure in elderly ESUS patients is not clear. The investigators designed this prospective register-based observational study to verify the efficacy of PFO-closure in elderly ESUS patients with high-risk PFO, older than 60 years

Conditions

  • Embolic Stroke of Undetermined Source

Interventions

PROCEDURE

PFO closure

PFO-closure will be performed after 3-6 month of observation and monitoring for paroxysmal atrial fibrillation

Sponsors & Collaborators

  • National Evidence-Based Healthcare Collaborating Agency

    collaborator OTHER_GOV

  • Asan Medical Center

    lead OTHER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-17
Primary Completion
2026-05-31
Completion
2027-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05238610 on ClinicalTrials.gov